CAS 13721-01-2
:1,4-Dihydro-4-oxo-3-chinolincarbonsäure
- 1,2-Dihydro-4-oxo-quinoline-3-carboxylic acid
- 1,4-Dihydro-4-Oxo-Quinoline-3-Carboxylic Acid
- 1,4-Dihydro-4-oxo-3-quinolinecarboxylic acid
- 1,4-dihydro-4-oxo-3-Quinolinecarboxylicacid
- 3-Quinolinecarboxylic acid, 1,4-dihydro-4-oxo-
- 4-Quinolone-3-carboxylic acid
- Aurora 17733
- Timtec-Bb Sbb000272
- 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid
1,4-Dihydro-4-oxoquinoline-3-carboxylic Acid
CAS:Formel:C10H7NO3Reinheit:>98.0%(T)(HPLC)Farbe und Form:White to Light yellow powder to crystalMolekulargewicht:189.173-Quinolinecarboxylic acid, 1,4-dihydro-4-oxo-
CAS:Formel:C10H7NO3Reinheit:98%Farbe und Form:SolidMolekulargewicht:189.16754-Oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS:4-Oxo-1,4-dihydroquinoline-3-carboxylic acidReinheit:99%Molekulargewicht:189.17g/mol4-Oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS:4-Oxo-1,4-dihydroquinoline-3-carboxylic acid is a synthetic compound that belongs to the class of quinoline derivatives. It has been shown to inhibit HIV infection in vitro by binding to the receptor CD4 on the surface of T cells. 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid has also been shown to be cytotoxic against cancer cells and other human cell lines. Powders of 4-oxo-1,4-dihydroquinoline 3 carboxylic acid have been synthesized by reacting ethyl esters with diphenyl ether in the presence of radiation or ndimethylformamide. This compound was also used as a molecular model for designing new drugs.
Formel:C10H7NO3Reinheit:Min. 98 Area-%Farbe und Form:Off-White PowderMolekulargewicht:189.17 g/mol4-Oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS:Formel:C10H7NO3Reinheit:95%Farbe und Form:SolidMolekulargewicht:189.174-Oxo-1,4-dihydroquinoline Carboxylic Acid
CAS:Kontrolliertes ProduktApplications 4-Oxo-1,4-dihydroquinoline Carboxylic Acid is a novel HIV-1 integrase strand transfer inhibitor.
References Shinkai, H. et al.: Antivir. Drugs. 197 (2011); Liao, C. et al.: ChemMedChem., 5, 1053 (2010);Formel:C10H7NO3Farbe und Form:NeatMolekulargewicht:189.17








